Skip to main content

Table 2 Outcomes in NSAID cohort and propensity-matched control cohort

From: NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

  NSAID Control
COVID-19 severity   
Moderate 18,023 (91.3%) 16,972 (86%)
Severe 776 (3.9%) 1047 (5.3%)
Dead 947 (4.8%) 1727 (8.8%)
Invasive ventilation 1150 (5.8%) 1867 (9.5%)
AKI 1729 (8.8%) 2437 (12.3%)
ECMO 54 (0.27%) 109 (0.55%)
  1. Number of patients and percent of cohort for each outcome are shown
  2. AKI acute kidney injury; ECMO extracorporeal membrane oxygenation